Bajaj Healthcare Limited receives consent from MPCB to resume operations at Tarapur Unit

Bajaj Healthcare Limited (BHL) a leading manufacturer of APIs, Intermediates and Formulations, has received consent from Maharashtra Control Board (MPCB) to resume its operations at Tarapur Unit, Plot No.: N-178, MIDC Tarapur, Boisar.

Maharashtra Pollution Control Board ("MPCB") had issued a notice on 14th January, 2021 to BHL directing the closure of operations at its unit situated at Plot No. N-178, MIDC, Tarapur, Boisar - 401506 for alleged violation of the provisions of Water (Prevention and Control of Pollution) Act 1974, Air (Prevention and Control Pollution) Act 1981 and the Rules made thereunder and furtherance to company's letter dated January 15, 2021.

BHL has now announced that the competent authority viz Maharashtra Pollution Control Board has vide its letter dated March 1, 2021 has given its consent to restart its manufacturing activities at the unit situated at Plot No.: N-178, MIDC Tarapur, Boisar.

Shares of Bajaj Healthcare Ltd was last trading in BSE at Rs.480 as compared to the previous close of Rs. 472.55. The total number of shares traded during the day was 15326 in over 503 trades.

The stock hit an intraday high of Rs. 488.8 and intraday low of 472. The net turnover during the day was Rs. 7350859.

Source : Equity Bulls

Keywords